About Rebecca Wolfe
Rebecca Wolfe is an executive officer at Myris Therapeutics.
Experience
This experience comes from Rebecca Wolfe's profile and from SEC filings. For roles taken from filings, the years are when the filings name Rebecca Wolfe in the role, so the role may have started earlier or lasted longer.
Myris Therapeutics, Inc. Current
Chief Operating Officer
2024 – Present · Sharpsburg, PA
Develops antibody-linked medicines for people with cancer.
OT
OncXerna Therapeutics
Vice President Program Management & Business Operations
2018 – 2023
EC
Eli Lilly and Company
Advisor (Director) Clinical Operations Implementation
2000 – 2018
BH
Brigham and Women's Hospital
Clinical Dietitian
1997 – 2000
Key Colleagues at Startups
The people Rebecca Wolfe works with at each company, as listed on that company's latest Form D.
Myris Therapeutics, Inc. · Form D, Oct 14, 2026
Laura Benjamin
CEO, Board Director
AS
Antonina Simakova
Executive officer
Alan Russell
Promoter
David Colaizzi
Board Chairman
BF
Barbara Fox
Board Director
Krzysztof Matyjaszewski
Co-Founder and Board Director
Mark Murcko
Board Director